Skip to main content
SpringerLink
Log in

Heterogeneity of calcium channels in mast cells and basophils and the possible relevance to pathophysiology of lung diseases: A review

  • Histamine and Kinins
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

Calcium plays a critical role in the formation and secretion of a wide variety of chemical mediators. Calcium slow-channel blockers,e.g. nifedipine and verapamil, have been shown to inhibit the synthesis of SRS (SRS-A, leukotrienes) in human and guinea pig lung tissue, thromboxane A2 formation in rat lung and platelet activating factor in human neutrophils. Verapamil and nifedipine also prevent the release of lysosomal enzymes from rabbit and human polymorphonuclear neutrophils. Calcium-channel blockers produce variable inhibitory effects on allergic and nonallergic histamine secretion. Ca++-entry blockers also inhibit the Ca++ uptake (influx) into mast cells. Many of these inhibitory effects of Ca++ antagonists are antagonized by an increased extracellular Ca++ ion concentration. The magnitude of the inhibitory influences of Ca++-channel blockers on allergic and nonallergic release of chemical mediators appears to depend on the cell source, species, nature and the concentration of the secretory stimuli as well as on the composition and pH of buffers and the concentration of Ca++-entry blockers used. The data summarized in this review suggest the existence of a functional heterogeneity of Ca++ channels in leukocytes, mast cells and basophils. Interference with the Ca++-dependent steps involved in the formation and/or release of chemical mediators appears to be the primary mode of action for Ca++-channel blockers in these cells.

The differential effects of Ca++ antagonists on Ca++-dependent activation of phospholipase A2, 5-lipoxygenase, and calmodulin (or other intracellular Ca++-binding proteins) in different cell types (mast cells, basophils, leukocytes, lung tissue, etc.) may explain the variation of their effectiveness in inhibiting the synthesis/release of chemical mediators and antagonizing bronchoconstriction in response to diverse stimuli.

During the process of hypersensitization and in immediate hypersensitivity diseases, Ca++ homeostasis (uptake, mobilization, distribution, relocation, etc.) may be altered in leukocytes (mast cells, basophils) and lung tissues. The altered Ca++ homeostasis could be responsible for the induction of airway hyperreactivity in asthmatics and for hyperreleasability of chemical mediators from leukocytes, mast cells and other cell types.

The development of drugs (Ca++-channel blockers, antiallergic agents) that are capable of selectively altering Ca++-dependent functions in leukocytes (mast cells, basophils, macrophages) and lung tissue in disease staes would offer an attractive alternative and an effective therapeutic approach for obstructive respiratory diseases,e.g. allergic asthma, exercise-induced asthma and a variety of other mediator-dependent allergic disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. J.C. Foreman,The Pharmacological Control of Immediate Hypersensitivity, Ann. Rev. Pharmac. Toxicol.21, 63–81 (1981).

    Google Scholar 

  2. F.L. Pearce,Calcium and Histamine Secretion from Mast Cells, Prog. Med. Chem.19, 59–109 (1982).

    PubMed  Google Scholar 

  3. E. Middleton, Jr.,Role of Calcium and Calcium Antagonists in Airway Function, Eur. J. Resp. Dis.64 (Suppl. 128), 123–132 (1983).

    Google Scholar 

  4. K.E. Andersson,Airway Hyperreactivity — Smooth Muscle and Calcium, Eur. J. Resp. Dis.64, 49–70 (1983).

    Google Scholar 

  5. D.J. Triggle,Airways Smooth Muscle and Calcium Transport, Immun. and Allergy Pract.5, 39–43 (1983).

    Google Scholar 

  6. W. Kazimierczak andB. Diamant,Mechanisms of Histamine Release in Anaphylactic and Anaphylactoid Reactions, Prog. Allergy,24, 295–365 (1978).

    PubMed  Google Scholar 

  7. R.G. Townley,Calcium Channel Antagonists in Coronary Artery Spasm and Bronchial Spasm, Chest82, 401–403 (1982).

    PubMed  Google Scholar 

  8. D.J. Triggle,Calcium, the Control of Smooth Muscle Function and Bronchial Hyperreactivity, Allergy38, 1–9 (1983).

    PubMed  Google Scholar 

  9. R.P. Siraganian,Histamine Secretion from Mast Cells and Basophils, Trends in Pharmac. Sci.4, 432–437 (1983).

    Google Scholar 

  10. E.B. Weiss andS.G. Viswanath,Calcium Hypersensitivity in Airways Smooth Muscle, Respiration.38, 266–272 (1979).

    PubMed  Google Scholar 

  11. J. Cerrina, A. Denjean, G. Alexandre, A. Lockhart andP. Duroux,Inhibition of Exercise-Induced Asthma by a Calcium Antagonist, Nifedipine, Am. Rev. Resp. Dis.123, 156–160 (1981).

    PubMed  Google Scholar 

  12. K.R. Patel,The Effect of Calcium Antagonist, Nifedipine, in Exercise-Induced Asthma, Clin. Allergy11, 429–432 (1981).

    PubMed  Google Scholar 

  13. P.A. Corris, S. Nariman andG.J. Gibson,Nifedipine in the Prevention of Asthma Induced by Exercise and Histamine, Am. Rev. Resp. Dis.128, 991–992 (1983).

    PubMed  Google Scholar 

  14. P.J. Barnes, N.M. Wilson andM.J. Brown,A Calcium Antagonist, Nifedipine, Modifies Exercise-Induced Asthma, Thorax36, 726–730 (1981).

    PubMed  Google Scholar 

  15. S.Y. So, W.K. Lam andD.Y.C. Yu,Effect of Calcium Antagonists on Allergen-Induced Asthma, Clin. Allergy12, 595–600 (1982).

    PubMed  Google Scholar 

  16. E. McIntyre, B. Fitzgibbon, H. Otto, R. Minson, J. Alpers andR. Ruffin,Inhaled Verapamil in Histamine-Induced Bronchoconstriction, J. Allergy and Clin. Immun.71, 375–381 (1983).

    Google Scholar 

  17. D. Patakas, E. Vlachoianni, V. Tsara, G. Louridas andP. Argiropoulou,Nifedipine in Bronchial Asthma, J. Allergy and Clin. Immun.72, 269–273 (1983).

    Google Scholar 

  18. K.R. Patel,The Effect of Verapamil on Histamine and Methacholine-Induced Bronchoconstriction, Clin. Allergy11, 441–447 (1981).

    PubMed  Google Scholar 

  19. T. Ringqvist,Effect of Verapamil in Obstructive Airways Disease, Eur. J. Clin. Pharmac.7, 61–64 (1974).

    Google Scholar 

  20. J.M. Gonzalez, R.C. Morice, K. Bloom, S. Akers, A.E. Raizner andP.M. Stevens,Inhibition of Airway Reactivity by Nifedipine in Patients with Coronary Artery Disease, Am. Rev. Resp. Dis.127, 155–157 (1983).

    PubMed  Google Scholar 

  21. P.E. Malo, M.A. Wasserman andR.L. Griffin,The Effects of Nifedipine and Verapamil on Antigen-Induced Bronchoconstriction in Dogs, Eur. J. Pharmac.92, 69–75 (1983).

    Google Scholar 

  22. P.E. Malo, M.A. Wasserman andR.L. Griffin,Effects of Intravenous and Aerosol Nifedipine on Prostaglandin F 2 α and Histamine-Induced Bronchoconstriction in Anesthetized Dogs, J. Pharm. Exp. Ther.221, 410–415 (1982).

    Google Scholar 

  23. T.M. Brugman, M.L. Darnell andC.A. Hirshman,Nifedipine Aerosol Attenuates Airway Constriction in Dogs with Hyperreactive Airways, Am. Rev. Resp. Dis.127, 14–17 (1983).

    PubMed  Google Scholar 

  24. E.W. Russi, B. Marchette, L. Yerger, W.M. Abraham andT. Ahmed,Modification of Allergic Bronchoconstriction by a Calcium Antagonist: Mode of Action, Am. Rev. Resp. Dis.127, 675–679 (1983).

    PubMed  Google Scholar 

  25. A.F. Henderson, R.W. Heaton, L.S. Dunlop andJ.F. Costello,Effects of Nifedipine on Antigen-Induced Bronchoconstriction, Am. Rev. Resp. Dis.127: 549–553 (1983).

    PubMed  Google Scholar 

  26. C.H. Fanta, C.S. Venugopalan, P.G. Lacouture andJ.M. Drazen,Inhibition of Bronchoconstriction in the Guinea Pig by a Calcium Channel Blocker Nifedipine, Am. Rev. Resp. Dis.125, 61–66 (1982).

    PubMed  Google Scholar 

  27. E.B. Weiss, J. Marlowicz andL. Barbero,Effect of Calcium Antagonists in Experimental Asthma, Allergy37, 513–519 (1982).

    PubMed  Google Scholar 

  28. K. Akagi, Y. Tanizaki, Y. Sano, A. Bewtra andR. Townley,Inhibitory Effects of Nifedipine on Allergic Reactions, Clin. Res.29, 688A (1981).

    Google Scholar 

  29. Y. Tanizaki, K. Akagi, K.N. Lee andR.G. Townley,Inhibitory Effect of Nifedipine and Cromolyn Sodium on Skin Reactions and 45Ca Uptake and Histamine Release in Rat Mast Cells Induced by Various Stimulating Agents, Int. Archs Allergy Appl. Immun.72, 102–109 (1983).

    Google Scholar 

  30. Y. Tanizaki, H. Komagoe, M. Sudo, J. Ohtani, I. Kimura, K. Akagi andR.G. Townley,Inhibitory Effect of the Ca 2+ Antagonist Nifedipine on Histamine Release from Rat Peritoneal Mast Cells, Acta Med. Okayama37, 207–211 (1983).

    PubMed  Google Scholar 

  31. M. Kurose,Inhibition of Anaphylactic Histamine Release from Heterologously Sensitized Mast Cells: Differential Effects of Drugs Which Interfere with Calcium Influx, Acta Med. Okayama35, 307–317 (1981).

    PubMed  Google Scholar 

  32. K. Saeki andM. Kurose,Histamine Release from Rat Mast Cells Sensitized with Mouse Antiserum, Agents and Actions11, 98–100 (1981).

    PubMed  Google Scholar 

  33. L.O. Lunardi andI. Vugman,Dual Effect of Verapamil on Rat Peritoneal Mast Cells: Inhibition or Induction of Histamine Release, Brazilian J. Med. Biol. Res.15, 269–273 (1982).

    Google Scholar 

  34. J. Descotes, A. Laschi, P. Tachon andJ.C. Evreux,Anti-anaphylactic Properties of Verapamil. First Experimental Assessment, J. Pharmac. (France)13, 573–578 (1982).

    Google Scholar 

  35. N. Chand, J. Pillar, V. Natarajan, W. Diamantis andR.D. Sofia,Inhibition of Allergic Histamine Secretion from Rat Peritoneal Mast Cells (RPMC) by Azelastine, a Novel, Orally Acting Antiallergic Agent, Pharmacologist25, 181 (1983).

    Google Scholar 

  36. W.L. Parker andE. Martz,Calcium Ionophore A23187 as a Secretagogue for Rat Mast Cells: Does It Bypass Inhibition by Calcium Influx Blockers?, Agents and Actions12, 276–283 (1982).

    PubMed  Google Scholar 

  37. M. Ennis, P.W. Ind, F.L. Pearce andC.T. Dollery,Calcium Antagonists and Histamine Secretion from Rat Peritoneal Mast Cells, Agents and Actions13, 144–148 (1983).

    PubMed  Google Scholar 

  38. J. Sierchio, D. Ritchie, C. Bishop andR. Capetola,Calcium Channel Blockers in Immediate Hypersensitivity, Pharmacologist25, 120 (1983).

    Google Scholar 

  39. B. Diamant andS.A. Patkar,Stimulation and Inhibition of Histamine Release from Isolated Rat Mast Cells, Int. Archs Allergy Appl. Immun.49, 183–207 (1975).

    Google Scholar 

  40. T. Suzuki, K. Mori andM. Uchida,Inhibition by Calcium Antagonists of Histamine Release and Calcium Influx of Rat Mast Cells: Difference Between Induction of Histamine Release by Concanavalin A and Compound 48/80, Eur. J. Pharmac.85, 155–161 (1982).

    Google Scholar 

  41. A.M. Magro,Effect of Inhibitors of Arachidonic Acid Metabolism Upon IgE and Non-IgE-Mediated Histamine Release, Int. J. Immunopharmac,4, 15–20 (1982).

    Google Scholar 

  42. E. Jouvin-Marche, J. Cerrina, E. Coeffier, P. Duroux andJ. Benveniste,Effect of the Ca 2+ Antagonist Nifedipine on the Release of Platelet-Activating Factor (PAF-Acether), Slow-Reacting Substance and β-Glucuronidase from Human Neutrophils, Eur. J. Pharmac.89, 19–26 (1983).

    Google Scholar 

  43. V. Lee, J.M. Hughes, J.P. Seale andD.M. Temple,Verapamil Inhibits Mediator Release from Human Lung In Vitro, Thorax38, 386–387 (1983).

    PubMed  Google Scholar 

  44. M. Damiano andE.J. Barbieri,Slow-Reacting-Substance (SRS) Release from Guinea Pig Lung: Inhibition by Calcium (Ca) Antagonists, Pharmacologist25, 144 (1983).

    Google Scholar 

  45. N. Chand, W. Diamantis, J Pillar andR.D. Sofia,Inhibition of Allergic and Nonallergic Histamine Secretion from Rat Peritoneal Mast Cells by Calcium Antagonists, Br. J. Pharmac.83: 899–902 (1984).

    Google Scholar 

  46. J. Cerrina, L. Hadji, E. Marche, P. Duroux andJ. Benveniste,Effect of the Ca 2+ Antagonist Nifedipine on Histamine and SRS Release from Human Lung Tissue, Am. Rev. Resp. Dis.125, 64 (1982).

    Google Scholar 

  47. C. Jensen, P.S. Skov andS. Norn,Inhibitory Effect of Calcium Antagonists on Histamine Release from Human Leukocytes, Allergy38, 233–237 (1983).

    PubMed  Google Scholar 

  48. S. Norn, C. Jensen andP.S. Skov,Inhibitory Effect of Calcium Antagonists on Basophil Histamine Release: In Vivo and In Vitro Studies, Br. J. Pharmac.77, 426P (1982).

  49. J.G.R. Elferink,Interference of the Calcium Antagonists Verapamil and Nifedipine with Lysosomal Enzyme Release from Rabbit Polymorphonuclear Leukocytes, Arzneim.-Forsch.32, 1417–1420 (1982).

    Google Scholar 

  50. E. Middleton, Jr., G. Drzewiecki andD. Triggle,Effects of Smooth Muscle Calcium Antagonists on Human Basophil Histamine Release, Biochem. Pharmac.30, 2867–2869 (1981).

    Google Scholar 

  51. F. Atkins, E. Middleton, D. Triggle andG. Drzewiecki,Effect of Calcium Antagonists on Human Basophil Histamine Release, J. Allergy and Clin. Immun.68, 28 (1981).

    Google Scholar 

  52. C.C. Srivastava andK.K. Awasthi,Arachidonic Acid Metabolism in Isolated Aorta and Lung of the Rat: Effects of Dipyridamole, Nifedipine, Propranolol, Hydralazine and Verapamil, Prostag. Leuk. & Med.10, 411–421 (1983).

    Google Scholar 

  53. R.M. Bedard andW.W. Busse,Nifedipine Inhibition of Human Basophil Histamine Release, J. Allergy and Clin. Immun.71, 104 (1983).

    Google Scholar 

  54. M. Kneussl, O. Burghuber, P. Harmuth, K. Silberbauer, E. Sinzinger andP. Haber,Nifedipine Protects Acetylcholine Induced Bronchoconstriction: The Role of Mediator Release, Am. Rev. Resp. Dis.127, 108 (1983).

    PubMed  Google Scholar 

  55. B.A. Jackschik, H. Sprecher andA.R. Sams,Modulation of Leukotriene Formation: inSRS-A and Leukotrienes, ed. P.J. Piper (John Wiley and Sons), p. 119 (1981).

  56. J.M. Mencia-Huerta, C. Akerman andJ. Benveniste,Phospholipase A 2 (PLA 2),Lipo-(LO), Cyclo (CO)-Oxygenase and Release of Platelet-Activating Factor (PAF) and Slow-Reacting Substance (SRS) from Rat Macrophages, Fed. Proc.39, 691 (1980).

    Google Scholar 

  57. G. Marone, A. Kagey-Sobotka andL.M. Lichtenstein,Possible Role of Phospholipase A 2 in Triggering Histamine Secretion from Human Basophils In Vitro, Clin. Immun. Immunopath.20, 231–239 (1981).

    PubMed  Google Scholar 

  58. N. Chand, J. Pillar, V. Natarajan, W. Diamantis andR.D. Sofia,Evidence for the Role of Phospholipase A 2 Activation in Allergic and Nonallergic Histamine Secretion, Prostaglandins & Leukotrienes, IV Internat. Sym., Washington, D.C. (1984). (Abstract #269)

  59. E.Y. Chi, W.R. Henderson andS.J. Klebanoff,Phospholipase A 2-Induced Rat Mast Cell Secretion. Role of Arachidonic Acid Metabolites, Lab. Invest.47, 579–585 (1982).

    PubMed  Google Scholar 

  60. S.P. Peters, A. Kagey-Sabotka, D.W. Magglashan, Jr.,M.I. Siegel andL.M. Lichtenstein,The Modulation of Human Basophil Histamine Release by Products of the 5-Lipoxygenase Pathway, J. Immun.129, 797–803 (1982).

    PubMed  Google Scholar 

  61. N. Chand,Possible Role for the Products of Arachidonate-Lipoxygenase Pathway as Regulators of Airway Reactivity and Release of Chemical Mediators, Kongr. Ber. Wiss. Tag. Norddtsch. Ges. Lungen- u. Bronchialheilk18, 93–103 (1983).

    Google Scholar 

  62. L. Levine,Inhibition of the A-23187-Stimulated Leukotriene and Prostaglandin Biosynthesis of Rat Basophil Leukemia (RBL-1) Cells By Nonsteroidal Antiinflammatory Drugs, Anti-oxidants, and Calcium Channel Blockers, Biochem. Pharmac.32, 3023–3026 (1983).

    Google Scholar 

  63. W. Diamantis, J. Pillar, V. Natarajan, N. Chand andR.D. Sofia,Inhibition of IgE-Mediated Allergic Histamine Release by Azelastine from Rabbit Basophils, Fed. Proc.43, 389 (1984).

    Google Scholar 

  64. C.A. Swenson, E. Dick andW. Busse,Influenza A Virus Enhanced Basophilic Leukocyte Histamine Release: A Calcium Flux Defect, J. Allergy and Clin. Immun.73, 165 (1984).

    Google Scholar 

  65. R.M. Bedard andW.W. Busse,Inhibition of Human Basophil Histamine Release by the Calcium Channel Antagonists, J. Allergy Clin. Immun.73, 166 (1984).

    Google Scholar 

  66. K. Akagi, F. Kohi andR. Townley,Basophil Spontaneous Histamine Release, J. Allergy and Clin. Immun.73, 166 (1984).

    Google Scholar 

  67. C.L. Anderson, R. Parish andW. Busse,Influenza A Virus Enhancement of Human Basophilic Leukocyte Histamine Release, J. Allergy and Clin. Immun.68, 28 (1981).

    Google Scholar 

  68. A. Legrand, J. Cerrina, C. Bonne, A. Lockhart andJ. Benveniste,Inhibition of Rat Mast Degranulation by Verapamil, Agents and Actions14, 153–156 (1984).

    Google Scholar 

  69. N. Chand, J. Pillar, W. Diamantis andR.D. Sofia,In Vitro Inhibition of Allergic Histamine Release by Calcium Antagonists, Eur. J. Pharmac.107, 353–358 (1985).

    Google Scholar 

  70. E.F. Nemeth andW.W. Douglas,Calmodulin, Phospholipase and Exocytosis p-bromophenacylbromide Inhibits but Mepacrine Stimulates Secretion in Rat Mast Cells, Naunyn-Schmiedeberg's Arch. Pharmac.324, 38–45 (1984).

    Google Scholar 

  71. N. Chand, J. Pillar, V. Natarajan, W. Diamantis andR.D. Sofia, Pharmacological Modification of Allergic and Nonallergic Histamine Release by Inhibitors of Arachidonic Acid (AA) Metabolism and Azelastine, Prostaglandins & Leukotrienes, IV Internat. Symp. (1984). (Abstract #268)

  72. D.M. Ritchie, J.N. Sierchio, C.M. Bishop, C.C. Hedli, S.L. Levinson andR.J. Capetola,Evaluation of Calcium Entry Blockers in Several Models of Immediate Hypersensitivity, J. Pharmac. Exp. Ther.229, 690–695 (1984).

    Google Scholar 

  73. K. Svedmyr, C. Lofdahl andN. Svedmyr,Nifedipine — a Calcium Channel Blocker in Asthmatic Patients, Allergy39, 17–22 (1984).

    PubMed  Google Scholar 

  74. D.C. Pang andN. Sperelakis,Uptake of Calcium Antagonists Drugs into Muscles as Related to Their Lipid Solubilities, Biochem. Pharmac.33, 821–826, (1984).

    Google Scholar 

  75. C. Lugnier, A. Follenius, D. Gerard andJ.C. Stoclet,Bepridil and Flunarizine as Calmodulin Inhibitors, Eur. J. Pharmac.98, 157–158 (1984).

    Google Scholar 

  76. J.R. Guerreo andS.S. Martin,Full Spectrum Calcium Channel Blocking Agents. An Overview, Med. Res. Rev.4, 87–109 (1984).

    PubMed  Google Scholar 

  77. F.L. Pearce,Mast Cell Heterogeneity, Trends in Pharmac. Sci.4, 165–167 (1983).

    Google Scholar 

  78. F. Shanahan, J.A. Denburg, J. Bienenstock, J. andA.D. Befus,Mast Cell Heterogeneity,Can. J. Physiol. Pharmac. 62, 734–737 (1984).

    Google Scholar 

  79. D.W. MacGlashan Jr., R.P. Schleimer, S.P. Peters, E.S. Schulman, G.K. Adams, A.K. Sobotka, H.H. Newball andL.M. Lichtenstein,Comparative Studies in Human Basophils and Mast Cells, Fed. Proc.42, 2504–2509 (1983).

    PubMed  Google Scholar 

  80. N. Chand, J. Pillar, W. Diamantis andR.D. Sofia,Inhibition of Allergic Histamine Release by Azelastine and Selected Antiallergic Drugs from Rabbit Leukocytes, Int. Archs Allergy Appl. Immun.97, 451–455 (1985).

    Google Scholar 

  81. N. Chand, J. Pillar, W. Diamantis andR.D. Sofia,Inhibition of Allergic and Nonallergic Histamine Release (HR) by Azelastine (AZ) and Lipoxygenase Inhibitors (LI), J. Allergy and Clin. Immunol.75, 194 (1985).

    Google Scholar 

  82. N. Chand, J. Pillar, W. Diamantis, J.L. Perhach, Jr. andR.D. Sofia,Inhibition of Calcium Ionophore (A23187)-Stimulated Histamine Release from Rat Peritoneal Mast Cells by Azelastine: Implications for its Mode of Action, Eur. J. Pharmac.96, 227–233 (1983).

    Google Scholar 

  83. N. Chand, J. Pillar, W. Diamantis andR.D. Sofia,Inhibition of IgE-Mediated Allergic Histamine Release from Rat Peritoneal Mast Cells by Azelastine and Selected Antiallergic Drugs, Agents and Actions16, 318–322 (1985).

    PubMed  Google Scholar 

  84. K.E. Barret, K.B.P. Leung andF.L. Pearce,Histamine Secretion and the Effect of Antiallergic Compounds on Peritoneal Mast Cells of the Rat, Br. J. Pharmac.78, 58P (1983).

  85. N. Chand, W. Diamantis andR.D. Sofia,Pharmacology of Azelastine: Possible Mode of Action, Congress of North German Society of Lung and Bronchial Medicine, Hamburg, West Germany (1985).

  86. D.A.S. Fields, J. Pillar, W. Diamantis, J.L. Perhach, Jr. andN. Chand,Inhibition by Azelastine of Nonallergic Histamine Release from Rat Peritoneal Mast Cells, J. Allergy Clin. Immunol.73, 400–403 (1984).

    PubMed  Google Scholar 

  87. A. Truneh andF.L. Pearce,Effect of Cyclic AMP, Disodium Cromoglycate and Other Antiallergic Drugs on Histamine Secretion from Rat Mast Cells Stimulated with the Calcium Ionophore Ionomycin, Agents and Actions14, 179–184 (1984).

    PubMed  Google Scholar 

  88. N. Chand, J. Pillar, W. Diamantis, J.L. Perhach, Jr. andR.D. Sofia,Inhibition of Calcium Ionophore (A23187)-Induced Histamine Release by A Novel Anti-allergic Agent, 4-(p-chlorobenzyl)-2-(Hexa-hdyrol-methyl-l H-azepine-4yl)-l(2H)-phthalazinone hydrochloride (azelastine; A5610), Int. J. Immuno-pharmac. 4, 342 (1982).

    Google Scholar 

  89. N. Chand, W. Diamantis andR.D. Sofia,In Vitro Model for Exercise (Cold)-Induced Asthma: I Experimental Details, Am. Rev. Resp. Dis.131, A3 (1985).

    Google Scholar 

  90. N. Chand, W. Diamantis andR.D. Sofia,In Vitro Model of Cold-Induced Asthma. II Possible Mechanism, Am. Rev. Resp. Dis.131, (1985).

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology Wallace Laboratories, Division of Carter-Wallace, Inc., 08512, Cranbury, New Jersey, U.S.A.

    N. Chand, J. L. Perhach Jr., W. Diamantis & R. D. Sofia

Authors
  1. N. Chand
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. L. Perhach Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. Diamantis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. D. Sofia
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chand, N., Perhach, J.L., Diamantis, W. et al. Heterogeneity of calcium channels in mast cells and basophils and the possible relevance to pathophysiology of lung diseases: A review. Agents and Actions 17, 407–417 (1986). https://doi.org/10.1007/BF01965507

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01965507

Keywords

Search

Navigation